Aperbio was established
Main business: nucleic acid testing and consulting services

Deepblue Cloud was established,
Focus on the introduction and marketing of innovative scientific instruments

Focus on liquid biopsy  qPCR/dPCR platform is used to develop tumor companion diagnostic products.

Introducing  Naica dPCR system, Aperbio is the technology promoter, and DeepBlue Cloud is the market sales entity.

Aperbio (Suzhou) Co., Ltd. was established.
Construction of GMP  and product registration and certification

National High-tech Enterprise
Jiangsu Science and Technology Enterprise
3 registration certificates 

Medical device production license
dPCR Naica CN and qPCR Cielo Dx

Specialized and innovative small and medium-sized enterprises
Digital PCR Platform Technology Research Center
3 product registration certificates approved

National Postdoctoral Preparatory Station
Re-certification of high-tech enterprises